Works matching IS 18696953 AND DT 2025 AND VI 16 AND IP 7


Results: 13
    1
    2
    3
    4
    5
    6

    Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease: Mapping Across Different Indian Populations (MAP Study).

    Published in:
    Diabetes Therapy, 2025, v. 16, n. 7, p. 1435, doi. 10.1007/s13300-025-01748-1
    By:
    • Mohan, Viswanathan;
    • Joshi, Shashank;
    • Kant, Saket;
    • Shaikh, Altamash;
    • Sreenivasa Murthy, L.;
    • Saboo, Banshi;
    • Singh, Parminder;
    • Sosale, Aravind R.;
    • Sanyal, Debmalya;
    • Shanmugasundar, G.;
    • Singh, Santosh Kumar;
    • Pancholia, A. K.;
    • Mondal, Sunetra;
    • George, Rishi;
    • Jaiswal, Ashok;
    • Jhaveri, Kunal
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Multicenter, Phase 4 Clinical Study from India to Evaluate the Safety and Efficacy of Insulin Glargine 300 U/ml in Insulin-Naïve People with Type 2 Diabetes Uncontrolled on Oral Anti-hyperglycemic Drugs: SAFEGUARD Study.

    Published in:
    Diabetes Therapy, 2025, v. 16, n. 7, p. 1367, doi. 10.1007/s13300-025-01736-5
    By:
    • Mohan, Viswanathan;
    • Sethi, Bipin;
    • Jain, Sunil M.;
    • Sahay, Rakesh;
    • Ramanathan, Balamurugan;
    • Murthy, Sreenivasa;
    • Singh, Kiran Pal;
    • Menon, Shalini;
    • Gadekar, Arvind;
    • Salvi, Vaibhav;
    • Gandhi, Kedar
    Publication type:
    Article